Vineet Veitla, MD

Publications

• Demystifying hyponatremia: A clinical guide to evaluation and management.

  (Bhasin-Chhabra B, Veitla V, Weinberg S, Koratala A.) Nutr Clin Pract. 2022 Oct;37(5):1023-1032 PMID: 36036229 SCOPUS ID: 2-s2.0-85136691529 08/30/2022

• Focused Cardiac Assessment in Kidney Care.

  (Veitla V, Bhasin B.) POCUS J. 2022;7(Kidney):45-50 PMID: 36896102 PMCID: PMC9994304 03/11/2023

• AKI in Hospitalized Patients with COVID-19 and Seasonal Influenza: A Comparative Analysis.

  (Bhasin B, Veitla V, Dawson AZ, Garacci Z, Sturgill D, Ozieh MN, Regner KR.) Kidney360. 2021 Apr 29;2(4):619-628 PMID: 35373047 PMCID: PMC8791326 SCOPUS ID: 2-s2.0-85107688077 02/26/2021

• North American Congress of Clinical Toxicology (NACCT) Abstracts 2021

  (Leah Patullo, Matt Stanton, Vineet Veitla, Susan Spaulding, David Gummin.) Clinical Toxicology. 11/02/2021

• AKI in Hospitalized Patients with COVID-19 and Seasonal Influenza: A Comparative Analysis

  (Bhavna Bhasin, Vineet Veitla, Aprill Z. Dawson, Zhuping Garacci, Daniel Sturgill, Mukoso N. Ozieh and Kevin R. Regner.) Kidney360. 01/01/2021

• Ischemic Colitis in Association with Sevelamer Crystals.

  (Keri KC, Veitla V, Samji NS.) Indian J Nephrol. 2019;29(3):191-193 PMID: 31142966 PMCID: PMC6521773 05/31/2019

• β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits.

  (Li H, Murphy T, Zhang L, Huang B, Veitla V, Scherlag BJ, Kem DC, Yu X.) Endocrinology. 2016 Jan;157(1):16-22 PMID: 26517045 SCOPUS ID: 2-s2.0-84954506000 10/31/2015

• A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.

  (Li H, Zhang L, Huang B, Veitla V, Scherlag BJ, Cunningham MW, Aston CE, Kem DC, Yu X.) J Interv Card Electrophysiol. 2015 Dec;44(3):205-12 PMID: 26446828 PMCID: PMC5812008 SCOPUS ID: 2-s2.0-84947128203 10/09/2015

• AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.

  (Liles C, Li H, Veitla V, Liles JT, Murphy TA, Cunningham MW, Yu X, Kem DC.) Hypertension. 2015 Oct;66(4):830-5 PMID: 26259590 PMCID: PMC4567423 SCOPUS ID: 2-s2.0-84941236707 08/12/2015

• Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.

  (Li H, Kem DC, Zhang L, Huang B, Liles C, Benbrook A, Gali H, Veitla V, Scherlag BJ, Cunningham MW, Yu X.) Hypertension. 2015 Apr;65(4):793-9 PMID: 25691619 PMCID: PMC4359052 SCOPUS ID: 2-s2.0-84937551556 02/19/2015

• Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.

  (Li H, Yu X, Cicala MV, Mantero F, Benbrook A, Veitla V, Cunningham MW, Kem DC.) J Am Soc Hypertens. 2015 Jan;9(1):15-20 PMID: 25537460 PMCID: PMC4314451 SCOPUS ID: 2-s2.0-84923095380 12/30/2014

• Demystifying hyponatremia: A clinical guide to evaluation and management

  (Bhavna Bhasin-Chhabra MD, Vineet Veitla MD, Samuel Weinberg MD, Abhilash Koratala MD.) Nutrition in clinical practice. Bhasin-Chhabra, B, Veitla, V, Weinberg, S, Koratala, A. Demystifying hyponatremia: A clinical guide to evaluation and management. Nutr Clin Pract. 2022; 1- 10. doi:10.1002/ncp.10907 08/29/2022